Stay updated with breaking news from Life Sciences Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Azenta (NASDAQ:AZTA – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas […]
Wall Street analysts expect that Azenta, Inc. (NASDAQ:AZTA – Get Rating) will announce earnings per share (EPS) of $0.11 for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Azenta’s earnings. The lowest EPS estimate is $0.10 and the highest is $0.12. Azenta reported earnings per share of $0.69 during the same […]
Wall Street brokerages expect that Brooks Automation Inc (NASDAQ:AZTA – Get Rating) will announce sales of $142.30 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Brooks Automation’s earnings, with estimates ranging from $142.00 million to $142.60 million. Brooks Automation reported sales of $286.59 million during the […]
/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the fiscal quarter ended December 31, 2021. Summary of Results Results of...
Merck KGaA will launch a new life sciences division that consolidates its current CDMO and contract testing units, plus other operations, as part of the pharma giant's move to position itself for future growth.